Vital KSK Holdings, Inc. (FRA:4GX)

Germany · Delayed Price · Currency is EUR

8.10

-0.10 (-1.22%)

At close: Jun 26, 2026

12.80% (1Y)

Market Cap	398.82M +6.8%
Revenue (ttm)	3.33B +1.7%
Net Income	40.16M +0.7%
EPS	0.83 +2.2%
Shares Out	n/a
PE Ratio	9.93
Forward PE	n/a
Dividend	34.20 (417.01%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	8.10
Previous Close	8.20
Day's Range	8.10 - 8.10
52-Week Range	7.18 - 8.65
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About Vital KSK Holdings

Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company sells poisonous or deleterious substances, narcotics, quasi-drugs, medical equipment and devices, sanitary materials, hygiene goods, nursing care products, and beverages; and test reagents, agricultural chemicals, epidemiological agents and materials, industrial chemicals, veterinary drugs, poisonous and deleterious substances, paints, pigments, dyes, regenerative medicine products, and other chemicals, as well as well as chemicals... [Read more]

Industry Medical, Dental, and Hospital Equipment and Supplies

Founded 2009

Employees 3,756

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 4GX

Financial Performance

In fiscal year 2026, Vital KSK Holdings's revenue was 610.50 billion, an increase of 1.69% compared to the previous year's 600.37 billion. Earnings were 7.36 billion, an increase of 0.74%.

Financial numbers in JPY Financial Statements